Document:

EX-10.25

 Exhibit 10.25 

EXECUTION COPY 
 EMPLOYMENT
AGREEMENT 
 This Employment Agreement (the “Agreement”) is entered into between Veritone, Inc., a
Delaware corporation (the “Veritone”), Veritone One, Inc., a Delaware corporation (“VOI”) and Ryan Steelberg (the “Executive”) effective as of this 14th day
of March, 2017 (the “Effective Date”). Veritone and VOI are collectively referred to herein as the “Company.” 

WHEREAS, the Company and Executive desire to enter into a written agreement to document the terms of the Executive’s employment
with the Company, which agreement shall replace in its entirety any prior employment agreement or understanding pursuant to which the Executive will continue to perform services to the Company. 

NOW, THEREFORE, on the basis of the foregoing and in consideration of the mutual covenants and agreements contained herein, the parties
hereto agree as follows: 
 1. Employment. The term of Executive’s employment under this Agreement shall be for a period of three
years commencing on the Effective Date and ending on third anniversary of the Effective Date, subject to earlier termination or renewal as provided in this Agreement (the “Employment Term”). Unless either party notifies the
other no later than ninety (90) days prior to the expiration of the Employment Term of its or his intention not to extend and renew, on the expiration of the Employment Term, and on each annual anniversary of the expiration of the Employment
Term, this Agreement shall automatically extend and renew for an additional one year period (each of which renewal periods shall form part of the Employment Term), subject to earlier termination as provided in the Agreement. If the Executive’s
employment terminates for any reason, the Executive shall not be entitled to any payments, benefits, damages, awards or compensation other than as provided by this Agreement. 

2. Duties and Location. During the Employment Term, the Executive shall be employed by the Company as the President of Veritone,
reporting directly to the Company’s Chief Executive Officer. Notwithstanding the foregoing, no action may be taken regarding (i) the termination of Executive’s Service with the Company (as defined in the Company’s equity
incentive plan then in effect (the “Stock Plan”)), or any other action listed in Section 7.2(b) below, without the approval of the Company’s Board of Directors (the “Board”) or
(ii) Executive’s compensation or bonus (without the approval of the Compensation Committee of the Board (the “Committee”). Executive shall have such duties, responsibilities and powers that are customary for an
individual holding the position of the President. Executive shall faithfully and diligently perform such duties of said office that are customary for an individual holding the position of the President, as well as such other lawful related duties of
an executive nature as may be reasonably requested by the Chief Executive Officer from time to time; provided however, that Executive shall continue to have material input regarding (a) the Annual Operating Plan to be established for the
Company each year; and (b) all merger and acquisition transactions, financing, technology and strategic transactions, and other material transactions undertaken by the Company. Executive shall devote substantially all of his business time and
effort to the performance of his duties hereunder (except for permitted vacation periods and reasonable periods of illness or other disability); provided however, nothing contained herein shall prohibit the Executive from engaging in
(i) charitable, civic and industry work, (ii) occasional lectures and teaching at educational and/or charitable institutes, (iii) subject to the 

 
consent of the Audit Committee or any other committee designated by the Board, service on boards of directors of non-competing companies, and
(iv) advising other companies or businesses as may be pre-approved in writing by the Company’s Audit Committee or any other committee designated by the Board; provided that, with respect to
(i) through (iv) above, such service, work or activities do not materially interfere with Executive’s performance of his duties to the Company (as determined by the Company’s Audit Committee or any other committee designated by the
Board after thirty (30) days’ notice to Executive and Executive’s opportunity to cure). Executive shall be based at the Company’s offices located in Newport Beach, California or at such other offices of the Company located within
thirty-five (35) miles of Executive’s residence as of the Effective Date. 
 3. Compensation. 

3.1. 2016 Compensation. In consideration for Executive’s services rendered to the Company during the year ended December 31,
2016, the Company shall pay to Executive a cash bonus in the amount of Three Hundred Fifty Thousand Dollars ($350,000), which bonus shall be payable as follows (i) $175,000 of such bonus shall be paid on or before March 15, 2017; and
(ii) the balance shall be payable upon the earlier of (A) 30 days prior written demand after the completion of the Company’s initial public offering pursuant to a registration statement on Form S-1
filed with the Securities and Exchange Commission (the “Initial Public Offering”); or (B) February 15, 2018. 

3.2. Annual Compensation. In consideration for the services rendered by Executive hereunder during the Employment Term, the Company
shall pay to Executive for services rendered on and after the Effective Date, during the Employment Term a base salary at the rate of Three Hundred Fifty Thousand Dollars ($350,000) per annum (the “Annual Salary”), which
shall be payable in accordance with the regular payroll practices of the Company applicable to senior executives (but in no event less frequently than on a monthly basis). The Compensation Committee shall review Executive’s Annual Salary (with
input from the Chief Executive Officer) at least on an annual basis and the Annual Salary may be increased from time to time at the discretion of the Compensation Committee. Any increase in Executive’s Annual Salary shall thereupon be the
“Annual Salary” for the purposes hereof. 
 3.3. Bonus. During the Employment Term, in addition to the Annual
Salary, commencing as of the of the current fiscal year and for each fiscal year of the Company thereafter during the Employment Term, Executive shall be entitled to receive bonuses (cash or otherwise), in the sole discretion of the Compensation
Committee, from time to time. Such bonuses may be based upon performance criteria established by the Compensation Committee; provided that the Compensation Committee shall be required to consult with Executive before establishing any specified
performance criteria for any fiscal year. 
 3.4. Applicable Withholdings. The Company shall deduct and withhold from all compensation
payable to Executive hereunder any and all applicable federal, state and local income and employment withholding taxes and any other amounts that the Company determines are required to be deducted or withheld by the Company under applicable
statutes, regulations, ordinances or orders governing or requiring the withholding or deduction of amounts otherwise payable as compensation or wages to employees. 

  
 2 

 4. Equity Grants. The Company shall grant to Executive the following two stock options,
which options shall be granted as of the date the underwriting agreement for the Initial Public Offering is signed (the “IPO Effective Date”) provided that Executive is in Service (as defined in the Stock Plan) with the
Company under this Agreement on such date, and such options shall have an exercise price per share equal to the price to the public in the Initial Public Offering. Such options shall be granted under the Company’s equity incentive plan then in
effect (the “Stock Plan”) and shall be subject to all of the terms and conditions of the Stock Plan and the form Notice of Grant of Stock Option and Stock Option Agreement approved for use under the Stock Plan, except as
otherwise provided herein. 
 4.1. Time-Based Option. The first stock option to be granted to Executive (the “Time-Based
Option”) shall be an option to purchase that number of shares of the Company’s Common Stock equal to five percent (5%) of the Company’s outstanding shares of capital stock as of the IPO Effective Date on a “Fully
Diluted Basis”, which shall give effect to (i) the issuance of shares in the Initial Public Offering; (ii) the conversion of all of the Company’s Preferred Stock in connection with the Initial Public Offering;
(iii) the conversion in full of all outstanding principal and accrued interest on the Acacia Secured Promissory Note dated August 15, 2016; (iv) the exercise in full of the Acacia Primary Common Stock Purchase Warrant dated August 15,
2016; (v) the assumed exercise in full of all other outstanding options and warrants to purchase shares of the Company’s capital stock as of the IPO Effective Date; and (vi) the assumed conversion of all other convertible securities of the
Company as of the IPO Effective Date. The Time-Based Option shall vest in 36 equal monthly installments upon Executive’s completion of each month of Service (as defined in the Stock Plan) over the three (3) year period measured from the
IPO Effective Date. 
 4.2. Performance-Based Option. The second stock option to be granted to Executive (the
“Performance-Based Option”) shall be an option to purchase that number of shares of the Company’s Common Stock equal to two and one-half percent (2.5%) of the Company’s
outstanding capital stock as of the IPO Effective Date, on a Fully Diluted Basis (as described above). The Performance-Based Option shall vest in full upon the earlier of (i) the date the market capitalization of the Company, based on the
closing price per share of capital stock of the Company’s Common Stock as reported on the Company’s primary stock exchange/market on such date multiplied by the number of shares of capital stock of the Company outstanding, equals or
exceeds Four Hundred Million Dollars ($400,000,000.00) for at least five consecutive trading days, or (ii) the fifth anniversary of the closing of the Initial Public Offering, provided that the Executive is still in the Service of the Company
(as defined in the Stock Plan) on such date. 
 4.3. Acceleration of Options. The vesting of the Time-Based Option and the
Performance-Based Option (collectively, the “Options”) shall accelerate (i) in full if the Company terminates Executive without Cause (as defined below); (ii) with respect to fifty percent (50%) of the then unvested
shares subject to the Options if the Executive resigns for Good Reason (as defined below); or (iii) if there is a Change in Control (as defined in the Stock Plan) in which the Options are not assumed in the Change in Control or are otherwise
cancelled in connection with the Change in Control; provided, however, that under subsection (iii) above, the Performance-Based Option shall only accelerate if the aggregate equity value of the Company in the Change in Control is equal or
greater than $400 million. 

  
 3 

 5. Benefits. During the Employment Term, the Executive will be eligible for all employee
benefits, and to participate in all employee benefit plans, which the Company makes available to its full-time employees, subject to the terms and conditions of the Company’s personnel policies or benefit plans, as applicable governing such
benefits. Such benefits shall include in any group life, hospitalization or disability insurance plans, health programs, retirement plans, fringe benefit programs and similar benefits that may be available to other senior executives of the Company
generally, on the same terms as such other executives, or such other benefits as programs as are currently being provided to Executive and his family, which shall include, without limitation, reimbursement by the Company for Executive’s
separate health insurance policy, on comparable terms as currently provided to Executive. Executive shall accrue vacation at a rate at least equal to twenty (20) days of paid vacation each calendar year pursuant to the Company’s then
existing vacation policy without regard to any caps on accrual of such vacation. In addition to the foregoing, Executive shall also be eligible for paid sick time and paid holidays provided to any other employees of the Company. 

6. Expenses. The Company shall promptly (but in no event later than the end of the calendar year following the calendar year during
which the expenses referred to below in this Section 6 are incurred) pay or reimburse Executive for all ordinary and reasonable out-of-pocket expenses actually
incurred (and, in the case of reimbursement, paid) by the Executive in the performance of the Executive’s services under this Agreement; provided that the Executive submits reasonable proof of such expenses in accordance with the Company’s
expense reimbursement policies then in effect for the Company’s employees. 
 7. Certain Terminations of Employment. 

7.1. Termination upon Death or Disability. If the Executive dies during the Employment Term, the Employment Term shall terminate as of
the date of death, and the obligations of the Company to or with respect to the Executive shall terminate in their entirety upon such date except as otherwise provided under this Section 7.1. If the Executive becomes Disabled (as defined
below), the Company shall have the right, to the extent permitted by law, to terminate the employment of the Executive upon notice in writing to the Executive. For purposes of this Agreement, the Executive will only be considered
“Disabled” if the Executive is unable by reason of accident or illness (including mental illness) to perform essential job functions of his position for more than 180 consecutive days with reasonable accommodation that does
not cause undue hardship. “Disability” will be determined by a physician reasonably acceptable to the Company and Executive or his legal representatives. If the Executive is terminated due to death or by reason of becoming
Disabled, (i) the Executive (or the Executive’s estate or beneficiaries in the case of the death of the Executive) shall be entitled to (A) any Annual Salary earned prior to the date of termination of employment,
(B) reimbursement under this Agreement for expenses incurred prior to the termination of employment; (C) payment for any earned but unused vacation days, (D) any other amounts to which Executive is legally entitled to as of the date
of his termination (the amounts in clauses (A) through and including (D) being the “Accrued Amounts”), and (E) any outstanding options held by Executive to the extent vested as of the date of such termination
may be exercised by Executive or Executive’s estate for a period of one year following termination of employment in accordance with this Section 7.1, and (ii) the Executive (or, in the case of his death, his estate and beneficiaries)
shall have no further rights to any other compensation or benefits hereunder on or after the termination of employment, or any other rights hereunder. Any payments made pursuant to this Section 7.1 shall be made within thirty (30) days of
the termination of the Executive’s employment with the Company. 

  
 4 

 7.2. Termination by the Company for Cause; Resignation of the Executive without Good Reason;
Expiration of the Employment Term. 
 (a) For purposes of this Agreement, “Cause” shall mean: (i) a breach
by the Executive of a material provision of the Agreement; or (ii) the Executive’s conviction, guilty plea or plea of nolo contendere for any crime involving financial impropriety, moral turpitude, or in any felony criminal proceeding, in
each case that was materially detrimental to the Company’s reputation or business; provided that, with respect to the actions, events or conditions described in clauses (i) and (ii) above, any termination by the Company shall be
presumed to be other than for Cause unless (A) the Company provides written notice to Executive of the applicable action, event or condition allegedly constituting Cause (which notice shall specify in reasonable detail the particulars of such
action, event or condition), and (B) if such condition can be cured, rescinded or remedied, the Executive fails to cure, rescind or otherwise remedy the applicable action, event or condition described in such written notice within thirty
(30) days after delivery of such written notice (or such longer period as the Company may agree in writing). 
 (b) For the purposes of
this Agreement, “Good Reason” shall mean Executive’s voluntary resignation from his employment with the Company for any one or more of the following events which occurs, without Executive’s written agreement that
such event will not constitute a “Good Reason” event: (i) a material reduction in the Executive’s duties, powers and responsibilities; (ii) if the Executive no longer reports directly to the Chief Executive Officer or the
Company’s reporting structure is changed so that any of the Company’s officer positions (which currently report to Executive) no longer report to the Executive; (iii) a material reduction in Executive’s compensation, which shall
deemed to have occurred if Executive’s Annual Salary has been reduced by ten percent (10%) or more without the Executive’s prior written consent; (iv) a relocation of the Company’s offices by more than thirty-five (35) miles
outside of Executive’s residence as of the date hereof; or (v) the Company’s breach of any material provision of this Agreement. In order for a termination to constitute a termination for “Good Reason” hereunder, Executive
must give the Company written notice of his intent to resign for Good Reason within ninety (90) days following the date Executive first learns of such Good Reason event, and the Company shall not have cured such Good Reason event within thirty
(30) days following receipt of such notice from the Executive and Executive’s employment must terminate upon expiration of such thirty (30)-day period. 

(c) If the Company terminates Executive for Cause, if the Executive resigns from the Company without Good Reason, or if Executive’s
employment terminates at the end of the Employment Term, then (i) the Executive shall receive the Accrued Amounts, and (ii) the Executive shall have no further rights to any other compensation or benefits hereunder on or after such
termination of employment. 

  
 5 

 7.3. Termination by the Company without Cause or Resignation for Good Reason.
Notwithstanding anything to the contrary contained herein, the Company may terminate the Executive’s employment at any time for any reason or no reason. If the Company terminates Executive’s employment with the Company during the
Employment Term without Cause (excluding a termination covered by Section 7.1) or Executive resigns for Good Reason, then the Executive shall receive (i) the Accrued Amounts, and (ii) if a general release of all claims as provided
below is executed and delivered by Executive to the Company, in the form attached as Exhibit A, and has become irrevocable, all within the fifty-two (52) days following termination (it being expressly
agreed and understood that other than the Accrued Amounts, no payment or benefit under this Section 7.3 shall be required to be paid or provided unless and until the foregoing release requirement is satisfied), then Executive shall receive full
payment of his Annual Salary (as in effect immediately before such termination) through the then current Employment Term in the form of a single lump sum payment, within sixty (60) days of such termination, subject to the requirements of 409A
as defined below (the “Severance”). Payment of Severance shall be conditioned on Executive’s execution (and non-revocation) of a general release of all claims against the
Company and its affiliates (subject to customary exceptions for continuing obligations covered by indemnification or director and officers insurance and share ownership) in the form attached hereto as Exhibit A; and the Executive shall have no
further rights to any other compensation or benefits hereunder on or after the termination of employment, or any other rights hereunder. All Severance due shall also be subject to Section 14.2. For avoidance of doubt, the termination of the
Executive’s employment at the end of the Employment Term shall not be treated as termination during the Employment Term without Cause eligible for Severance. 

8. Section 280G Matters. In the event that any payment, accelerated vesting or other benefit payable to Executive under this
Agreement together with any other benefits received by Executive under any other Agreement would constitute “parachute payments” within the meaning of Section 280G of the Internal Revenue Code (the “Code”)
(“Parachute Payments”), the following rules shall apply: If at such time the Company is not an entity whose stock is readily tradable on an established securities market (and the Company is otherwise eligible to use the
exception in Section 280G(b)(5)(A)(ii)) and if the Executive agrees to waive the right to receive and/or repay any Parachute Payment as required by applicable regulations under Section 280G(b)(5) of the Code (a “280G
Waiver”), the Company shall seek to obtain stockholder approval in accordance with the terms of Section 280G(b)(5)(A)(ii) and the regulations thereunder. If at such time either Section 280G(b)(5)(A) is not available for the Company or
the Executive does not provide a 280G Waiver, then Executive will be entitled to receive either (i) the full amount of the Parachute Payments, or (ii) the maximum amount that may be provided to Executive without resulting in any portion of
such Parachute Payments being subject to the excise tax imposed by Section 4999 of the Code, whichever of clauses (i) and (ii), after taking into account applicable federal, state, and local taxes and the excise tax under Section 4999
of the Code, results in the receipt by Executive, on an after-tax basis, of the greatest portion of the Parachute Payments. The repayment and/or reduction of payments or benefits which would be Parachute
Payments (each a “Payment”) contemplated by the preceding sentence shall be implemented by determining the Parachute Payment Ratio (as defined below) for each Payment and then reducing the Payments in order beginning with the
Payments with the highest Parachute 

  
 6 

 
Payment Ratio. For Payments with the same Parachute Payment Ratio, such Payments shall be reduced based on the time of payment of such Payments, with amounts having later payment dates being
reduced first. For Payments with the same Parachute Payment Ratio and the same time of payment, such Payments shall be reduced on a pro rata basis (but not below zero) prior to reducing Payments with a lower Parachute Payment Ratio. Any such
repayment or reduction will in all events comply with 409A. For purposes of the foregoing, “Parachute Payment Ratio” shall mean a fraction, the numerator of which is the value of the applicable Payment for purposes of Section
280G and the denominator of which is the intrinsic value of such Payment. 
 9. Indemnification Agreement. The Company shall enter
into an indemnification agreement with Executive in substantially the form of indemnification agreement adopted by the Company for the Company’s officers and directors. 

10. At Will Agreement. Executive’s employment with the Company is at will, which means that it may be terminated by either the
Company or Executive at any time, for any reason, without reason, and without advance notice. 
 11. Covenants of the Executive. As
condition of employment hereunder, Executive shall sign and deliver to the Company the Company’s form of Employee Information and Proprietary Information and Inventions Assignment Agreement, in substantially the form attached hereto as Exhibit
B, to the extent such form agreement has not been previously executed by the Executive. 
 12.
Non-Solicitation. Executive covenants and agrees that for one (1) year following the date on which Executive’s employment is terminated, regardless of the reason that Employee’s
employment is terminated, Executive shall not directly or indirectly: (a) solicit for employment to any then current employee of the Company (including, without limitation, any person employed by the Company after the date hereof), or
(b) encourage any person, vendor or supplier to terminate such person’s employment or relationship with the Company, as applicable. Notwithstanding the foregoing, nothing herein shall prevent the Executive from placing general
advertisements for employment which are not specifically directed to, or intended to encourage response from, the other party’s employees, or from hiring individuals who respond to such advertisements. This provision shall be in addition to the
non-solicitation provision set forth in the PIIAA, which shall remain in full force and effect. 

13. Representations and Warranties of the Executive. The Executive represents and warrants to the Company as follows: 

13.1. This Agreement will be duly executed and delivered by the Executive and (assuming due execution and delivery hereof by the Company) will
be the valid and binding obligation of the Executive enforceable against the Executive in accordance with its terms. 
 13.2. Neither the
execution and delivery of this Agreement by the Executive nor the performance of this Agreement in accordance with its terms and conditions by the Executive (i) requires the approval or consent of any governmental body or of any other person or
(ii) conflicts with or results in any breach or violation of, or constitutes (or with notice or lapse of time or both would constitute) a default under, any agreement, instrument, judgment, decree, order, statute, rule, permit or governmental
regulation applicable to the Executive. 

  
 7 

 13.3. The representations and warranties of the Executive contained in this Section 13 shall
survive the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby. 
 14. Other
Provisions. 
 14.1. Severability. If it is determined that any of the provisions of this Agreement, is invalid or unenforceable,
the remainder of the provisions of this Agreement shall not thereby be affected and shall be given full effect, without regard to the invalid portions. 

14.2. Section 409A Matters. This Agreement is intended to comply with Section 409A of the Internal Revenue Code of 1986, as
amended (the “Code”), and its corresponding regulations (“Section 409A”), or an exemption thereto, and payments may only be made under this Agreement upon an event and in a manner permitted by Section
409A, to the extent applicable. Severance benefits provided under this Agreement are intended to be exempt from Section 409A under the “separation pay exception” to the maximum extent applicable. Further, any payments that qualify for the
“short-term deferral” exception or another exception under Section 409A shall be paid under the applicable exception. All separation payments to be made upon a termination of employment under this Agreement may only be made upon a
“separation from service” under Section 409A. For purposes of Section 409A, the right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments. In no event may the Executive,
directly or indirectly, designate the calendar year of a payment. If a payment that is subject to execution of the release could be made in more than one taxable year, payment shall be made in the later taxable year. All reimbursements and in-kind benefits provided under the Agreement shall be made or provided in accordance with the requirements of Section 409A, including, where applicable, the requirement that (i) any reimbursement is for
expenses incurred during the period of time specified in this Agreement, (ii) the amount of expenses eligible for reimbursement, or in kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in
kind benefits to be provided, in any other calendar year, (iii) the reimbursement of an eligible expense will be made no later than the last day of the calendar year following the year in which the expense is incurred, and (iv) the right
to reimbursement or in kind benefits is not subject to liquidation or exchange for another benefit. If the Executive is treated as a “specified employee” (as determined by the Company in its discretion in accordance with applicable
regulations under Section 409A of the Code) at the time of his or her separation from service (within the meaning of Section 409A of the Code) from the Company and each employer treated as a single employer with the Company under Section 414(b) or
(c) of the Code, and if any amount(s) of nonqualified deferred compensation (within the meaning of Section 409A of the Code) are payable under this Agreement by reason of the Employee’s separation from service, then payment of the amounts
so treated as nonqualified deferred compensation which would otherwise be payable during the six month period following the Employee’s separation from service will be delayed until the earlier of (i) the first business day which is at
least six months and one day following the date of such separation from service, (ii) the death of the Employee, or (iii) such earlier date on which payment is permitted under Section 409A(a)(2)(B) of the Code. 

  
 8 

 14.3. Notices. Any notice or other communication required or permitted hereunder shall be
in writing and shall be (i) delivered personally, (ii) sent by reputable overnight courier that guarantees next business day delivery or (iii) sent by certified or express mail, postage prepaid (return receipt or signature
confirmation of receipt required). Any such notice shall be deemed given when so delivered personally, or if sent via reputable overnight courier, one business day after the date of deposit with such courier or, if mailed (certified and/or express
mail), five days after the date of deposit in the United States mails as follows: 
  

	 	(a)	If to Veritone and/or VOI, to: 

 Veritone, Inc. 

3366 Via Lido 
 Newport Beach,
CA 92663 
 Attention: General Counsel 

with a copy to: 
 Morgan,
Lewis & Bockius, LLP 
 600 Anton Boulevard, Suite 1800 

Costa Mesa, CA 92626 
 Attn:
Ellen S. Bancroft, Esq. 
  

	 	(b)	If to the Executive, to: 

 Ryan Steelberg 

(at Executive’s last residence as 

provided by Executive to the 

Company for payroll records) 

with a copy to: 
 Chris Erwin,
Esq. 
 Erwin Legal PC 
 47
Discovery, Suite 160 
 Irvine, California 92618 

Any such person may by notice given in accordance with this Section 14.3 to the other parties hereto designate another address or person for receipt by
such person of notices hereunder. 
 14.4. Board Action. Any actions permitted or required by the Board under this Agreement must be
taken by the Board at a meeting of the Board, duly noticed and held. 
 14.5. Return of Property and Resignation. Promptly upon the
Executive’s termination from employment, the Executive shall return all property of the Company and its affiliates and shall resign as an officer of the Company and its affiliates. 

  
 9 

 14.6. Entire Agreement. This Agreement contains the entire agreement between the parties
with respect to the subject matter hereof and supersedes all prior representations, understandings or agreements, written or oral, made by the Company or any of its officers, directors, stockholders or attorneys with respect thereto. 

14.7. Waivers and Amendments. This Agreement may be amended, superseded, canceled, renewed or extended, and the terms hereof may be
waived, only by a written instrument signed by the parties or, in the case of a waiver, by the party waiving compliance. No delay on the part of any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor
shall any waiver on the part of any party of any such right, power or privilege nor any single or partial exercise of any such right, power or privilege, preclude any other or further exercise thereof or the exercise of any other such right, power
or privilege. 
 15. Governing Law; Venue THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE
OF CALIFORNIA APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO CONFLICTS OF LAWS. Executive and the Company consent to the exclusive jurisdiction of, and venue in, the state courts in Orange County in
the State of California (or in the event of exclusive federal jurisdiction, the courts of the Central District of California) in connection with any dispute regarding the meaning, effect, performance or validity of this Agreement or arising out of,
related to, or in any way connected with Executive’s employment with the Company or services rendered hereunder. 
 16.
Arbitration. The parties agree that any and all disputes, claims, or controversies between the parties to this Agreement, including any dispute, claim or controversy arising out of or relating to an interpretation, construction, performance
or breach of this Agreement, shall be settled by arbitration to be held in Orange County, California administered by the American Arbitration Association in accordance with its then existing Commercial Arbitration Rules. The Federal Arbitration Act
(“FAA”) shall apply to the interpretation of this arbitration provision. The arbitrator may grant injunctions or other relief in such dispute or controversy. The decision of the arbitrator shall be final, conclusive and
binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in any court having jurisdiction. The parties will pay the costs and expenses of such arbitration in such proportions as the arbitrator shall
decide, and each party shall separately pay his own attorneys’ fees and expenses. 
 17. Binding Effect. Successors and Assigns; No
Third-Party Beneficiaries. This Agreement shall inure to the benefit of, and be binding upon, the successors and assigns of each of the parties, including, but not limited to, the Company’s successor-in-interest, the Executive’s heirs and the personal representatives of the Executive’s estate; provided, however, that neither party shall assign or delegate any of the obligations created
under this Agreement without the prior written consent of the other party. Notwithstanding the foregoing, the Company shall have the unrestricted right to assign this Agreement and its rights hereunder and to delegate all or any part of its
obligations hereunder to the Company’s successor in the event of any sale, transfer or other disposition of all or substantially all of the Company’s assets or business, whether by merger, consolidation or otherwise, but in such event such
assignee shall expressly assume all 

  
 10 

 
obligations of the Company hereunder. In the event the Company has had a Change in Control and the Company is not the surviving party or successor in such Change in Control, then the Company
agrees to have such successor or surviving party expressly assume the Company’s obligations under this Agreement. Nothing in this Agreement shall confer upon any person or entity not a party to this Agreement, or the legal representatives of
such person or entity, any rights or remedies of any nature or kind whatsoever under or by reason of this Agreement. 
 18.
Counterparts. This Agreement may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an original but all such counterparts together shall constitute one and the same instrument.
Each counterpart may consist of two copies hereof each signed by one of the parties hereto. 
 19. Headings. The headings in this
Agreement are for reference only and shall not affect the interpretation of this Agreement. 
 [SIGNATURES ON NEXT PAGE] 

  
 11 

 EXECUTION COPY 

IN WITNESS WHEREOF, the parties hereto have signed their names as of the day and year written below. 

 

			
	VERITONE, INC.
		
	By:	 	 /S/ PETER COLLINS

Peter F. Collins,
 Chief Financial Officer

	
	Date: March 14, 2017
	
	VERITONE ONE, INC.
		
	By:	 	 /S/ PETER COLLINS

Peter F. Collins,
 Chief Financial Officer

	
	Date: March 14, 2017
	
	 /S/ RYAN STEELBERG

	RYAN STEELBERG
	
	Date: March 14, 2017

 VERITONE, INC. 

SIGNATURE PAGE TO EMPLOYMENT AGREEMENT 

 Exhibit A 

Form of Release 

  
 13 

 GENERAL RELEASE 

This GENERAL RELEASE (this “Agreement”) is made and entered into by and between
                    (hereinafter “Executive”) and Veritone, Inc. (hereinafter “Employer”), and inures
to the benefit of Employer’s current, former and future parents, subsidiaries, related entities, employee benefit plans and their fiduciaries, predecessors, successors, officers, directors, shareholders, agents, employees and assigns of
Employer. 
 RECITALS 

A. Executive has worked for Employer for a period of time in an executive capacity, and has received substantial equity in Employer for the
services that he provided to Employer. 
 B. Executive’s employment with Employer ended
effective                    . 
 C.
Executive and Employer wish permanently to resolve any and all disputes arising out of the termination of Executive’s employment with Employer. 

NOW, THEREFORE, for and in consideration of the execution of this Agreement and the mutual covenants contained in the following
paragraphs, Employer and Executive agree as follows: 
 1. No Admission of Liability. The parties agree that the execution of this
Agreement, and the performance of the acts required by it, does not constitute an admission of liability, culpability, negligence or wrongdoing on the part of anyone, and will not be construed for any purpose as an admission of liability,
culpability, negligence or wrongdoing by any party. 
 2. Wages and Vacation Time Paid. Executive acknowledges that he as a result of
the equity and other consideration that he received, he was fully and completely compensated for all services that he provided to Employer. 

3. Release Benefit. Pursuant to the terms of Executive’s Employment Agreement, he is entitled to certain benefits if he agrees to
release all known and unknown claims against Employer (the “Release Benefits”). Executive acknowledges and agrees that he is not entitled to the Release Benefits unless and until he executes this General Release. 

4. General Release. Executive for himself, his heirs, executors, administrators, assigns and successors, fully and forever releases and
discharges Employer and each of its current, former and future parents, subsidiaries, related entities, employee benefit plans and their fiduciaries, predecessors, successors, officers, directors, shareholders, agents, employees and assigns
(collectively, “Releasees”), with respect to any and all claims, liabilities and causes of action, of every nature, kind and description, in law, equity or otherwise, which have arisen, occurred or existed at any time prior
to the signing of this Agreement, including, without limitation, any and all claims, liabilities and causes of action arising out of or relating to Executive’s employment, Executive’s employment agreement, grants of equity interests to
Executive, and cessation of Executive’s employment with Employer. 
 5. Release of Employment Related Claims. Executive
understands and agrees that he is waiving any and all rights he may have had, now has, or in the future may have, to pursue against any of the Releasees any and all remedies available to him under any employment-related causes of action, including,
without limitation, claims for unpaid wages, wrongful discharge, breach of contract, breach of the covenant of good faith and fair dealing, fraud, violation of public policy, defamation, discrimination, physical injury, emotional distress, claims
under Title VII of the Civil Rights Act of 1964, as amended, the Age Discrimination in Employment Act, the Americans With Disabilities Act, the Federal Rehabilitation Act, the Family and Medical Leave Act, the California Fair Employment and Housing
Act, the Equal Pay Act of 1963, the California Family Rights Act, the provisions of the California Labor Code and any other federal, state or local laws and regulations relating to employment, conditions of employment (including wage and hour laws)
and/or employment discrimination. Executive understands, however, that this Agreement does 

 
not extend to claims that may not be released as a matter of law. In addition, Executive understands and agrees that this release does not prevent Executive from making a complaint with,
contacting, or participating in an investigation with a federal governmental agency such as the Equal Employment Opportunity Commission, the Department of Labor, and the Securities and Exchange Commission, but does waive and release any claim for
damages or monetary relief associated with such a complaint or communication. 
 6. Release of Disputed Wage Claims. Executive
understand and agrees that Executive is releasing all claims related to disputes over wages owed to employees, including but not limited to, disputed wages, vacation, bonuses, overtime, break premiums, and any other type or form of disputed
compensation for time worked. 
 7. Release of Unknown Claims. Executive expressly waives any and all rights and benefits conferred
upon him by Section 1542 of the Civil Code of the State of California, which states as follows: 
 A general release does not extend
to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor. 

Executive expressly agrees and understands that the release given by him pursuant to this Agreement applies to all unknown, unsuspected and unanticipated
claims, liabilities and causes of action which he may have against Employer or any of the other Releasees. 
 8. Entire Agreement.
Executive acknowledges and agrees that no promises or representations were made to him which do not appear in this Agreement, and that this Agreement contains the entire agreement of the parties on its subject matter. Executive acknowledges and
agrees that he enters into this Agreement based upon his own judgment and not in reliance upon any representations or promises made by Employer or anyone acting on behalf of Employer, other than those contained within this Agreement. The parties
further agree that if any of the facts or matters upon which they now rely in making this Agreement prove to be otherwise, this Agreement will nonetheless remain in full force and effect. 

9. Voluntary Execution. Executive hereby acknowledges that he has read and understands this Agreement and that he signs this
Agreement voluntarily and without coercion. Executive further acknowledges that he has been advised by Employer to obtain independent legal advice regarding the matters contained in this Agreement. Executive further acknowledges that the waivers he
has made in this Agreement are knowing, conscious and voluntary and are made with full appreciation that he is forever foreclosed from pursuing any of the rights waived.

10. Severability. If any provision of this Agreement, it will not affect the enforceability of the remaining provisions and all
remaining provisions will be enforced to the extent permitted by law. 
 11. Modification. The parties agree that no waiver, amendment
or modification of any of the terms of this Agreement shall be effective unless in writing and signed by all parties affected by the waiver, amendment or modification. No waiver of any term, condition or default of any term of this Agreement shall
be construed as a waiver of any other term, condition or default. 
 12. Governing Law; Venue. THIS AGREEMENT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF CALIFORNIA APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO CONFLICTS OF LAWS. Executive and the Company consent to the exclusive jurisdiction of,
and venue in, the state courts in Orange County in the State of California (or in the event of exclusive federal jurisdiction, the courts of the Central District of California) in connection with any dispute regarding the meaning, effect,
performance or validity of this Agreement or arising out of, related to, or in any way connected with Executive’s employment with the Company or services rendered hereunder. 

  
 2 

 13. Arbitration. The parties agree that any and all disputes, claims, or controversies
between the parties to this Agreement including any dispute, claim or controversy arising out of or relating to an interpretation, construction, performance or breach of this Agreement, shall be settled by arbitration to be held in Orange County,
California administered by the American Arbitration Association in accordance with its then existing Commercial Arbitration Rules. The Federal Arbitration Act (“FAA”) shall apply to interpretation of this arbitration provision. The
arbitrator may grant injunctions or other relief in such dispute or controversy. The decision of the arbitrator shall be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in
any court having jurisdiction. The parties will pay the costs and expenses of such arbitration in such proportions as the arbitrator shall decide, and each party shall separately pay his own attorneys’ fees and expenses. Executive and Employer
waive any right to bring or pursue class or representative claims in arbitration. Executive understands that by signing this Agreement, Executive waives any right to bring a class, collective, or representative claim against Employer, and any
arbitration will be on behalf of Executive only. 
 14. Time for Consideration. Executive understands that he is entitled to have 21
days’ time in which to consider this Agreement. Employer advises Executive to obtain the advice and counsel from the legal representative of his choice. Executive executes this Agreement having had sufficient time within which to consider its
terms. Executive represents that if he executes this Agreement before 21 days have elapsed, he does so voluntarily, upon the advice and with the approval of his legal counsel, and that he voluntarily waives any remaining consideration period. 

15. Revocation. Executive understands that after executing this Agreement, he has the right to revoke it within seven (7) days
after his execution of it. Executive understands that this Agreement will not become effective and enforceable unless the seven day revocation period passes and Executive does not revoke this Agreement in writing. Executive understands that this
Agreement may not be revoked after the seven day revocation period has passed. Executive understands that any revocation of this Agreement must be made in writing and delivered to Employer at 3366 Via Lido, Newport Beach, CA 92663 within the seven
(7) day period. 
 BY SIGNING THIS AGREEMENT, EXECUTIVE REPRESENTS THAT EXECUTIVE READ THIS AGREEMENT AND KNOWS THAT EXECUTIVE GIVES UP IMPORTANT
RIGHTS. 
  

			
	Dated: 	  	  

		  	Executive

  
 3 

 Exhibit B 

Employee Proprietary Information and Invention Assignment Agreement 

(attached hereto) 

  
 14 

 VERITONE, INC. 

EMPLOYEE NONDISCLOSURE 

AND 
 PROPRIETARY
INFORMATION AND INVENTIONS AGREEMENT 

 

 In consideration of my employment with, and the compensation I receive from Veritone, Inc., a Delaware
corporation, and/or its wholly owned subsidiaries, Veritone One, Inc., Veritone Enterprise, LLC., and Veritone Politics, LLC., all of which are Delaware legal entities, together with their respective current and future
subsidiaries and affiliated companies (collectively, the “Company”), including without limitation the shares and stock options to be granted to me by the Company, I hereby represent and agree as follows: 

1. Confidential and Proprietary Information. I understand that the Company possesses and will possess Proprietary and Confidential Information
which is important to its business. For purposes of this Agreement, “Confidential and Proprietary Information” is generally any and all nonpublic information that was or will be developed, created or discovered by or on
behalf of the Company, or which became or will become known by, or was or is conveyed to the Company, which relates to and has commercial value in the Company’s Business (as hereinafter defined). I acknowledge that all right, title and interest
in and to such Confidential and Proprietary Information is vested with the Company, unless I can establish that (a) such information is or becomes publicly known through lawful means; (b) such information was rightfully in my possession or
part of my general knowledge prior to my work or service with or employment by the Company; or (c) such information is disclosed to me without confidential or proprietary restriction by a third party who rightfully possesses the information
(without confidential or proprietary restriction) and who did not learn of it from the Company. For purposes of this Agreement, the term “Company’s Business” shall mean the development, marketing and licensing of software/firmware for
artificial intelligence applications (including, without limitation, the Company’s software platform, elements thereof and applications therefor), the operation of an advertising agency, and services related to such lines of business. 

1.1. Confidential and Proprietary Information includes, without limitation, information (whether developed by me or conveyed orally, in
writing, or otherwise embodied in any form of media, and whether developed or conveyed before, upon or after the date hereof) relating to (i) all nonpublic information relating to the Company’s internal communications to its employees,
consultants, directors, shareholders, agents, clients, customers, vendors and suppliers, (ii) client/customer lists, vendor/supplier/partner lists, or other lists or compilations containing client,

 
customer, vendor, supplier or partner information; (iii) nonpublic information about the Company’s products or services, proposed products or services, research, product development, know-how, ideas, concepts, inventions, techniques, formulations, trade secrets, processes, costs, profits, markets, business plans, marketing plans, strategies, forecasts, financial statements, financing plans,
budgeting, valuations, capitalizations, sales or commissions, and product flow charts; (iv) plans for the future development or new product concepts; (v) design, manufacturing, marketing, pricing, sales or distribution techniques or
processes, documents, books, papers, drawings, schematics, models, prototypes, sketches, computer programs, databases or other data, including electronic data recorded or retrieved by any means; (vi) the skills, performance and terms of
employment or service of other employees, consultants, service providers or independent contractors; (vii) software in various stages of development, and any designs, drawings, schematics, specifications, techniques, source code, algorithms,
object code, documentation, diagrams, flow charts, research development, new product concepts, data sets, processes and procedures relating to any software; (viii) all other information that has been or will be developed by me in the course of
my work on behalf of the Company or given to me in confidence by the Company; and (ix) any information described above which the Company obtains from another party and which the Company treats as proprietary, designates as Confidential and
Proprietary Information, or otherwise has a confidentiality obligation with respect thereto. 
 1.2. I understand that the Company
possesses or will possess Company Materials which are important to its business. For purposes of this Agreement, “Company Materials” are documents or other media or tangible items that contain or embody or otherwise describe
Confidential and Proprietary Information, or any other information concerning the business, operations or plans of the Company, whether such documents have been prepared by me or by others. Company Materials include, without limitation, files,
blueprints, drawings, photographs, charts, graphs, notebooks, presentations, business plans, financial and accounting records, customer/client lists, vendor lists, supplier lists, partner lists, computer software, computer network diagrams and
schematics, media or printouts, audio and/or video recordings and other printed, typewritten or handwritten documents, as well as samples, prototypes, models, products and the like.

 

  
 Page 1 of 6 

 
 2. Intellectual Property. 

2.1. Subject to the provisions of Section 1 (a), (b) and (c) of this Agreement, all Confidential and
Proprietary Information and Company Materials and all right, title and interest in and to any patents, patent rights, copyrights, trademark rights, mask work rights, trade secret rights, and all other intellectual and industrial property and
proprietary rights that currently exist or may exist in the future anywhere in the world in connection with, or related to such Confidential and Proprietary Information or Company Materials (collectively the “Rights”) shall
be the sole property of the Company. I hereby assign to the Company any Rights I may have (to the extent not previously transferred to the Company) or hereafter acquire in such Confidential and Proprietary Information and Company Materials. 

2.2. At all times, both during my employment with the Company and after its termination, I will keep in confidence and trust and will not use
or disclose, directly or indirectly, in whole or in part, any Confidential and Proprietary Information, Company Materials or anything relating to it without the prior written consent of an executive officer of the Company except as may be necessary
and appropriate in the ordinary course of performing my duties to the Company. The disclosure restrictions of this Agreement shall not apply to any information that I can document that is generally known to the public through no fault of mine. 

2.3. Notwithstanding the foregoing, as may be required to comply with legal process, I may disclose Confidential and Proprietary Information
and/or Company Materials in response to a valid subpoena or request for production of documents issued by a court or governmental agency having jurisdiction over me and any Confidential and Proprietary Information and/or Company Materials, provided
that I give prompt notice to the Company of any such subpoena or request served on me, cooperate with the Company and its counsel with seeking a protective order over any such requested Confidential and Proprietary Information and/or Company
Materials, and limit any required disclosure to the Confidential and Proprietary Information and/or Company Materials specifically required by the requesting judicial or governmental agency. 

2.4. Nothing contained herein will prohibit an employee from disclosing to anyone the amount of his or her wages. 

2.5. I agree that during my employment or service with the Company, I will not remove any Company Materials from the business premises of the
Company or deliver any Company Materials to any person or entity outside the Company, except as provided in Section 2.3 above, or as necessary or appropriate in connection with performing the duties of my employment with the Company. I further
agree that, immediately upon the

 
termination of my employment by me or by the Company for any reason, or for no reason, or during my employment if so requested by the Company, I will return all Confidential and Proprietary
Information, Company Materials, apparatus, equipment and other physical property, or any reproduction of such property, excepting only (i) my personal copies of records relating to my compensation; (ii) my personal copies of any materials
previously distributed generally to stockholders of the Company; and (iii) my copy of this Agreement. 
 2.6. I understand that
nothing in this Agreement limits or impedes me from communicating with the Securities and Exchange Commission (“SEC”) about possible securities law violations or alleged facts relating to such violations. Employer will not enforce or
threaten to enforce this Agreement as to direct communications between me and the SEC. 
 2.7. I understand that federal law provides
certain protections to individuals who disclose a trade secret to their attorney, a court, or a government official in certain, confidential circumstances. Specifically, federal law provides that an individual shall not be held criminally or civilly
liable under any federal or state trade secret law for the disclosure of a trade secret under either of the following conditions: 
  

	 	•	 	Where the disclosure is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating
a suspected violation of law; or 

  

	 	•	 	Where the disclosure is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. See 18 U.S.C. § 1833(b)(1)). 

Federal law also provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the
trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret,
except pursuant to court order. See 18 U.S.C. § 1833(b)(2). 
 3. Inventions.  

I agree that all “Inventions” (which term includes, without limitation, patentable or
non-patentable inventions, original works of authorship, derivative works, trade secrets, trademarks, copyrights, service marks, discoveries, patents, technology, algorithms, computer software, application
programming interfaces, protocols, formulas, compositions, ideas, designs, processes, techniques, know-how and data related to the Company’s Confidential and Proprietary Information and all improvements,
rights and claims related to the foregoing), which I make, conceive, reduce to practice or develop (in whole or in part, either alone or

 

  
 Page 2 of 6 

 
jointly with others) in the course of my work or service with, or employment by, the Company that relate to or are used in the Company’s Business or relate to the Company’s actual or
demonstrably anticipated research or development (whether before, upon or after the date of this Agreement), shall be the sole property of the Company to the maximum extent permitted by law, including Section 2870 of the
California Labor Code, if applicable. 
 3.1. I hereby irrevocably assign, without further consideration, all such Inventions to the
Company (free and clear of all liens and encumbrances), and the Company shall be the sole owner of all Rights in connection therewith. Notwithstanding the foregoing, no assignment in this Agreement shall extend to inventions, the assignment of which
is prohibited by California Labor Code Section 2870, which states: 
 Any provision in an employment agreement
which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the
employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either: 
  

	 	(1)	Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or 

 

	 	(2)	Result from any work performed by the employee for the employer. 

 I acknowledge that all original works
of authorship made by me (in whole or in part, either alone or jointly with others) within the scope of my work with the Company (prior to my employment) or my employment with the Company that are protectable by copyright are “works made
for hire,” as defined in the United States Copyright Act (17 USCA, Section 101). I will not disclose Inventions covered by this Section 3.2 to any person outside the Company other than
as necessary or appropriate in connection with performing the duties of my employment with the Company, unless I am requested to do so by the Board of Directors of the Company. Any assignment of copyright hereunder (and any ownership of a copyright
as a work made for hire) includes all rights of paternity, integrity, disclosure and withdrawal and any other rights that may be known as or referred to as moral rights (collectively, the “Moral Rights”). To the extent
such Moral Rights cannot be assigned under applicable law and to the extent the following is allowed by the laws in the various countries where Moral Rights exist, I hereby waive such Moral Rights and consent to any action of the Company that would
otherwise violate such Moral Rights in the absence of such waiver and consent. I will confirm any such waivers and consents from time to time as requested by the Company.

 3.2. I agree to maintain adequate and current written records on the development of all
Inventions and to disclose promptly to the Company all such Inventions and relevant records, which records shall be deemed Company Materials and accordingly, will remain the sole property of the Company. I further agree that all information and
records pertaining to any idea, process, trademark, service mark, invention, technology, computer program, original work of authorship, design, formula, discovery, patent, or copyright that I do not believe to be an Invention, but is conceived,
developed, or reduced to practice by me (in whole or in part, either alone or jointly with others) during my employment, shall be promptly disclosed to the Company’s General Counsel (such disclosure to be received in confidence). The Company
shall examine such information to determine if, in fact, the ideas, process, or invention, etc., constitutes an Invention subject to assignment under Section 3. 

3.3. I agree to perform, during and after my employment, all acts deemed necessary or desirable by the Company to permit and assist it, at
the Company’s expense, in evidencing, perfecting, obtaining, maintaining, defending and enforcing Rights and/or my assignment with respect to such Inventions in any and all countries. Such acts may include, without limitation, execution of
documents and assistance or cooperation in legal proceedings. Should the Company be unable to secure my signature on any document necessary to apply for, prosecute, obtain, enforce or defend any Rights relating to any assigned Invention, whether due
to my mental or physical incapacity or any other cause, I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents, as my agents and
attorneys-in-fact, with full power of substitution, to act for and in my behalf and instead of me, to execute and file any documents and to do all other lawfully
permitted acts to further the above purposes with the same legal force and effect as if executed by me. 
 3.4. I represent that I have
validly assigned to the Company all Inventions and all Rights in patentable or non-patentable inventions, original works of authorship, derivative works, trade secrets, trademarks, copyrights, service marks,
discoveries, patents, technology, algorithms, computer software, application programming interfaces, protocols, formulas, compositions, ideas, designs, processes, techniques, know-how and data that
(a) relate to or are used in the Company’s Business (including, without limitation, the Company’s software platform, elements thereof and applications therefor) or relate to actual or demonstrably anticipated research or development
and (b) I have, alone or jointly with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of my work or service with or employment by the Company. I agree

 

  
 Page 3 of 6 

 
that my obligations under Section 3.4 shall extend to the assignments described in the preceding sentence. In addition, if I incorporate, integrate or use (or allow the incorporation,
integration and use) of any inventions owned by me, or in which I have an interest (that do not constitute works made for hire owned by the Company or are not otherwise assigned to the Company) into/with a Company product, process, service,
software, machine or other technology, I hereby grant to the Company a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to (directly or indirectly) reproduce, perform, display, create derivative works, distribute, transmit,
make, have made, modify, manufacture, practice, import use, sell and otherwise commercially exploit all such inventions as part of, or in connection with, such Company product, process, service, software, machine or other technology. 

3.5. I understand that nothing in this Agreement is intended to expand the scope of protection provided me by Sections 2870 through
2872 of the California Labor Code or any analogous provision of any other jurisdiction. 
 4. Prior Actions and Knowledge. I represent
and warrant that from the time of my first contact or communication with the Company, I have held in strict confidence all Confidential and Proprietary Information and have not (i) disclosed any Confidential and Proprietary Information or
delivered any Company Materials, in whole or in part, to anyone outside of the Company, or (ii) used, copied, published, or summarized any Confidential and Proprietary Information, or removed any Company Materials, in whole or in part, from the
business premises of the Company, except to the extent necessary to carry out my responsibilities as an employee of the Company. 
 5. Former Employer
Information. I agree that I will not, during the term of my employment with the Company, improperly use or disclose any confidential information, proprietary information or trade secrets of my former or concurrent employers that have not
previously been validly assigned to the Company. I agree that I will not bring onto the premises of the Company any document or any property belonging to my former employers unless previously consented to in writing by them, which I will demonstrate
by providing a copy of such written consent to the Company. I represent and warrant that I have returned all property and confidential information belonging to all prior employers. 

6. No Conflict with Obligations to Third Parties. I represent and warrant that my performance of all the terms of this Agreement will not breach
any agreement to keep in confidence proprietary or confidential information acquired by me in confidence or in trust prior to my employment with the Company. I represent and warrant that I have not entered into, and I agree that I will not enter
into, any agreement, either written or oral, in conflict herewith, or in conflict with my employment with the Company, or with any of my obligations under this Agreement.

 7. Non-Solicitation of Company Service Providers. During
the term of my employment with the Company and for one (1) year thereafter, I will not encourage or solicit, directly or indirectly, any person who is personally providing services to the Company as an employee, consultant or independent
contractor (each, a “Service Provider”) to reduce or terminate his or her employment or services to the Company for any reason. As part of this restriction, I will not interview or provide, directly or indirectly, any input
to any third party regarding any such Service Provider during the one (1) year period subsequent to the termination of my employment with the Company. However, this restriction will not affect any responsibility that I may have as an employee
of the Company with respect to the bona fide hiring and firing of Company personnel. 
 8. Duty of Loyalty. I agree that, during my employment
with the Company, I will not provide consulting services to, or become an employee of, any other firm or person engaged in a business that is in any way competitive with the Company without first informing the Company of the existence of such
proposed relationship and obtaining the prior written consent of the Company’s Chief Executive Officer, or Chief Financial Officer. 
 9. Company
Authorization for Publication. Prior to my submitting or disclosing for possible publication or dissemination outside the Company, any material prepared by me that incorporates information that concerns the Company’s Business or
anticipated research, I agree to deliver a copy of such material to an executive officer of the Company for his or her review. Within twenty (20) days following such submission, the Company agrees to notify me in writing whether the Company
believes such material contains any Confidential and Proprietary Information or Inventions, and I agree to make such deletions and revisions that are reasonably requested by the Company to protect its Confidential and Proprietary Information and
Inventions. I further agree to obtain the written consent of an executive officer of the Company prior to any review of such material by persons outside the Company. 

10. Name and Likeness Rights, Etc. During my employment with the Company, I hereby authorize the Company to use, reuse, and to grant
others the right to use and reuse, my name, photograph, likeness (including caricature), voice, and biographical information, and any reproduction or simulation thereof, in any media now known or hereafter developed (including but not limited to
film, video and digital or other electronic media), for whatever purposes the Company deems reasonably necessary. 

 

  
 Page 4 of 6 

 
 11. Remedies. I recognize that nothing in this Agreement is intended to limit any remedy of the
Company under the California Uniform Trade Secrets Act. I recognize that my violation of this Agreement could cause the Company irreparable harm, the amount of which may be extremely difficult to estimate, making any remedy at law or in damages
inadequate. Therefore, I agree that the Company shall have the right to apply to any court of competent jurisdiction for an order restraining any breach or threatened breach of this Agreement and for any other relief the Company deems appropriate
without the need to post a bond or any other security. This right shall be in addition to any other remedy available to the Company. In addition, I recognize that the unauthorized taking of any of the Company’s trade secrets (a) is a crime
under California Penal Code Section 499c and may be punishable by imprisonment in a state prison or in a county jail for a time not exceeding one (1) year, or by a fine not exceeding Five Thousand Dollars ($5,000), or by both such fine
and such imprisonment; and (b) could result in civil liability under the California Uniform Trade Secrets Act, among other laws or legal theories, and that such willful misappropriation may result in an award against me for triple the amount of
the Company’s damages and the Company’s attorneys’ fees in collecting such damages. 
 12. Notification. I hereby authorize the
Company to notify my actual or future employers of the terms of this Agreement and my responsibilities hereunder. 
 13. Survival. I agree that
my obligations under Section 1, Section 2, Section 3, and the provisions of Sections 11 through 17 of this Agreement shall continue in effect after
termination of my employment, regardless of the reason or reasons for termination, and whether such termination is voluntary or involuntary on my part, and that the Company is entitled to communicate my obligations under this Agreement to any future
employer or potential employer of mine. 

 14. Governing Law; Severability. I agree that any dispute regarding the meaning, effect or
validity of this Agreement shall be resolved in accordance with the laws of the State of California without regard to the conflict of law provisions thereof, even if I may work for the Company outside of California or the United States. I further
agree that if one or more provisions of this Agreement are held to be illegal or unenforceable, such illegal or unenforceable provision(s), or any portion thereof, shall be limited or excluded from this Agreement to the minimum extent required so
that this Agreement shall otherwise remain in full force and effect and enforceable in accordance with its terms thereof. 
 15. Successors and
Assigns. This Agreement shall be binding upon me, my heirs, executors, assigns, and administrators and shall inure to the benefit of the Company and its successors and assigns. I understand and agree that the terms of this Agreement will
continue to apply to me even if I transfer my duties at some time during the term of my employment from my employment with Veritone, Inc. or one of Veritone’s subsidiaries, to any other parent, subsidiary or other company affiliated with
Veritone, Inc. 
 16. Entire Agreement; Modification. The terms of this Agreement (including all attached Exhibits, which are incorporated
herein by this reference) are the final expression of my agreement with respect to its subject matter herein and may not be contradicted by evidence of any prior or contemporaneous agreement or understanding, whether oral or written. This Agreement
can only be modified by a subsequent written agreement executed by me and an executive officer of the Company. 
 17. Certification of
Compliance. I agree that upon termination of my employment with the Company, for any reason, I shall re-read this Agreement, and I will sign and remit to the Company a certification of my compliance
with this Agreement, in the form attached hereto as Exhibit A, no later than five (5) days after the effective date of my termination of my employment with the Company.

 

  
 I HAVE READ THIS AGREEMENT CAREFULLY
AND I UNDERSTAND AND ACCEPT THE OBLIGATIONS WHICH IT IMPOSES UPON ME WITHOUT RESERVATION. NO PROMISES OR REPRESENTATIONS HAVE BEEN MADE TO ME TO INDUCE ME TO SIGN THIS AGREEMENT. 

 

							
	Date:	  	March         , 2017	  		  	  

		  		  	Ryan Steelberg

  
 Page 5 of 6 

 EXHIBIT A 

CERTIFICATION OF COMPLIANCE 
 I certify
that I have received a copy of the Employee Nondisclosure and Proprietary Information and Inventions Assignment Agreement (the “Agreement”) that I signed in connection with my employment with Veritone, Inc., or a subsidiary
or an affiliate thereof (together and separately, the “Company”). 
 I certify that I have complied with, and will continue to
comply with, the Agreement including, without limitation: 
  

	1.	My obligations under Section 2 of the Agreement to preserve the confidentiality of all “Confidential and Proprietary Information” (as defined in the Agreement), and to not disclose
nor use any Company Confidential and Proprietary Information unless necessary in the performance of my job duties and responsibilities as an employee of the Company, or as may be expressly authorized in writing by an executive officer of the
Company; 

  

	2.	My obligation under Section 2 of the Agreement to return to the Company, and to not keep or otherwise retain, any and all “Company Materials” (as defined in the Agreement) as well as
any Company apparatus, equipment or other physical property; and 

  

	3.	My obligations under Section 7 of the Agreement with respect to non-solicitation of “Service Providers” (as defined in the Agreement) of the
Company. 

 I understand that this Certification of Compliance in no way limits my rights and obligations or the Company’s rights and
obligations, under the Agreement. 
  

									
	 Date:
	 	  
	 		  	  
	 	
		 		 		  	Former Employee Signature	 	
					
		 		 		  	  
	 	
		 		 		  	Former Employee Name (Please Print)EX-10.26

 Exhibit 10.26 

EXECUTION COPY 

FIRST AMENDMENT TO 

PRIMARY COMMON STOCK PURCHASE WARRANT 

This First Amendment (this “Amendment”), dated as of March 14, 2017 (the “Effective
Date”), amends that certain Primary Common Stock Purchase Warrant, dated August 15, 2016 (the “Primary Warrant”), by and between Veritone, Inc., a Delaware corporation (“Company”) and
Acacia Research Corporation, the holder of the Primary Warrant (“Holder”). All capitalized terms used in this Amendment but not otherwise defined herein shall have the respective meanings ascribed to such terms in the
Primary Warrant. 
 WHEREAS, Section 8(n) of the Primary Warrant requires the written consent of each of Company and Holder to
amend or waive any terms of the Primary Warrant. 
 WHEREAS, the Company and the Holder wish to amend the Primary Warrant; 

NOW, THEREFORE, in consideration of the foregoing and the promises and covenants contained herein, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the undersigned hereby agree as follows: 

1. Amendment to Section 2. Section 2 of the Primary Warrant is hereby amended and restated in its entirety as
follows: 
 “Section 2. Term. The Holder is entitled, at any time on or after the date hereof
and at or prior to the close of business on the fifth anniversary of the date hereof (the “Termination Date”) but not thereafter, to subscribe for and purchase all or any portion of the Warrant Shares from the Company, upon the terms and
subject to the conditions set forth herein; provided, that, Holder may not Exercise (as defined below) this Warrant for Warrant Shares until the date that is twelve (12) months from the original date of issuance of this Warrant. Notwithstanding
the foregoing, if the Company consummates its first Public Offering at any time prior to the Termination Date, this Warrant (or any remaining portion thereof) shall be automatically exercised in full with cash upon the consummation of such Public
Offering at the Exercise Price as set forth in Section 3(b)(ii) below, and the Holder hereby agrees to complete such automatic exercise and purchase all remaining Warrant Shares within three (3) business days of the closing date of such Public
Offering.” 
 2. Amendment to Section 3(a). Section 3(a) of the Primary Warrant is hereby amended and restated in its entirety as
follows: 
 “(a) Exercise of the purchase rights represented by this Warrant may be made in whole or in part, at any
time or times on or after the date hereof and on or before the Termination Date, by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder
appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto (a “Notice of Exercise”); provided, that, Holder may not Exercise this Warrant for Warrant Shares until the date that is
twelve 

 (12) months from the date hereof. In the case of an automatic exercise of this Warrant upon the
occurrence of the first Public Offering of the Company as set forth in Section 2 above, the Holder hereby agrees to Exercise this Warrant and purchase all remaining Warrant Shares for the applicable Exercise Price in the manner set forth in
Section 2 above. Within three (3) Business Days following the date of a Notice of Exercise, or the closing date of the Public Offering in the case of an automatic exercise, the Holder shall deliver to the Company (i) the aggregate
Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise, by wire transfer or cashier’s check drawn on a United States bank, and (ii) this Warrant and/or any certificate or certificates representing this
Warrant. Partial Exercises of this Warrant resulting in purchases of a portion of the Warrant Amount available at the time of such Exercise shall have the effect of lowering the Warrant Amount by such portion. The Holder and the Company shall
maintain records showing the portions of the Warrant Amount purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within two (2) Business Days of receipt of such notice. 

3. Amendment to Section 3(b). Section 3(b) of the Primary Warrant is hereby amended and restated in its entirety as follows: 

“(b) Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be (i) prior to
the consummation of the first Public Offering of the Company (x) if this Warrant is exercised in full, either (1) $8.1653 if the entire Convertible Amount from inception of the Secured Promissory Note has not been converted in full into
Conversion Shares or (2) $7.9817 if the entire Convertible Amount from inception of the Secured Promissory Note has been converted in full into Conversion Shares or (y) if this Warrant is not exercised in full, either (1) $8.1653 if the entire
Convertible Amount from inception of the Secured Promissory Note has been converted in full into Conversion Shares or (2) $8.2394 if the entire Convertible Amount from inception of the Secured Promissory Note has not been converted in full into
Conversion Shares, in each case as determined at the time of delivery of the applicable Notice of Exercise and subject to adjustment as provided in Section 4; or (ii) upon the consummation of the first Public Offering of the Company and
pursuant to the automatic exercise provision set forth in Section 2 above, the lower of (1) $8.1653 and (2) the initial public offering price per share of Common Stock in such Public Offering, in each case as determined at the time of
delivery of the applicable Notice of Exercise and subject to adjustment as provided in Section 4 (the “Exercise Price”).” 

4. Amendment to Exhibit A. The Exhibit A to the Primary Warrant, the Form of 10% Warrant, shall be replaced in its entirety with the new
Exhibit A attached hereto. 
 5. Governing Law. This Amendment will be governed by, and construed and enforced in accordance with, the
laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any other jurisdiction
other than the State of Delaware. In furtherance of the foregoing, the internal Laws of the State of Delaware will control the interpretation and construction of this Secured Promissory Note, even though under that jurisdiction’s choice of law
or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily apply. 

  
 2 

 6. Full Force and Effect. Except as amended hereby, the Primary Warrant shall remain in
full force and effect. 
 7. Counterparts. This Amendment may be executed in counterparts, and any party hereto may execute such
counterpart, each of which when executed and delivered shall be deemed to be an original and both of which counterparts taken together shall constitute but one and the same instrument. This Amendment shall become effective when all Parties hereto
shall have received a counterpart hereof signed by the other Parties hereto. The Parties agree that the delivery of this Amendment may be effected by means of an exchange of electronic signatures with original copies to follow by mail or courier
service. 
 8. Headings. Headings in this Amendment are included for reference only and shall have no effect upon the construction or
interpretation of any part of this Amendment. 
 9. Severability. The illegality or unenforceability of any provision of this
Amendment or any instrument or agreement required hereunder shall not in any way affect or impair the legality or enforceability of the remaining provisions of this Amendment or any instrument or agreement required hereunder. 

10. Entire Agreement. This Amendment embodies the entire agreement and understanding among the parties hereto and supersedes all prior
or contemporaneous agreements and understandings of such parties, verbal or written, relating to the subject matter hereof. 

  
 3 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to the Primary Warrant to be
duly executed by their respective authorized officers as of the date first above written. 
  

			
	COMPANY
	VERITONE, INC.
		
	By:	 	 /S/ PETER COLLINS

	Name: Peter F. Collins
	Title: Chief Financial Officer
	
	HOLDER
		
	By:	 	 /S/ CLAYTON J. HAYNES

	Name:	 	Clayton J. Haynes
	Title:	 	CFO

  
 4 

 EXHIBIT A 

FORM OF 10% WARRANT 
 See
attached. 

  
 5 

 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH
SECURITIES UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH MUST BE REASONABLY ACCEPTABLE TO THE COMPANY. 
 COMMON
STOCK PURCHASE WARRANT 
 VERITONE, INC. 
  

			
	Warrant Shares: ____________________	  	Date of Issuance: __________, [20XX]

 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received,
Veritone, Inc., a Delaware corporation (the “Company”), hereby grants to Acacia Research Corporation, a Delaware corporation (the ”Holder”), subject to the terms and conditions set forth herein, the right to
purchase up to 1,349,001 shares (the “Warrant Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 3(b). 
 Section 1. Definitions. Capitalized terms used and not
otherwise defined herein shall have the meanings set forth in (i) that certain Investment Agreement, dated as of the date hereof (the “Investment Agreement”), by and among the Holder and the Company, or (ii) that certain Secured
Promissory Note, dated as of the date hereof (the “Secured Promissory Note”), by and among the Holder and the Company, as the case may be. 

Section 2. Vesting Schedule; Term. 

(a) Vesting Schedule. The Warrant Shares shall vest as follows: (i) 674,501 Warrant Shares will vest and become exercisable on the date
hereof (the “Initial Exercise Date”); and (ii) the remaining 674,500 Warrant Shares shall vest and become exercisable on the one-year anniversary of the date hereof (the “Second
Exercise Date” and, together with the Initial Exercise Date, each, an “Exercise Date”). 

  
 1 

 (b) Term. The Holder is entitled, at any time on or after each respective Exercise Date
and at or prior to the close of business on the fifth anniversary of the date hereof (the “Termination Date”) but not thereafter, to subscribe for and purchase all or any portion of the then Exercisable Warrant Shares from the
Company, upon the terms and subject to the conditions set forth herein. For purposes hereof, “Exercisable Warrant Shares” means, as of any date, any and all Warrant Shares (or other securities to which the Holder is entitled pursuant to
Section 4) that have vested and become exercisable prior to such date in accordance with Section 2(a). 
 Section 3.
Exercise. 
 (a) Exercise of the purchase rights represented by this Warrant may be made with respect to any then Exercisable Warrant
Shares, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the
registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto (a “Notice of Exercise”). Within three (3) Business Days
following the date of exercise as aforesaid, the Holder shall deliver to the Company (i) the aggregate Exercise Price for the Exercisable Warrant Shares specified in the applicable Notice of Exercise, by wire transfer or cashier’s check
drawn on a United States bank (unless the cashless exercise procedure specified in Section 3(c) below is specified in the applicable Notice of Exercise), and (ii) this Warrant and/or any certificate or certificates representing this Warrant.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the number of Warrant Shares purchasable hereunder by an amount equal to the applicable
number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within two
(2) Business Days of receipt of such notice. 
 (b) Exercise Price. The exercise price per share of the Common Stock under this
Warrant shall be (i) if such Exercise occurs prior to the consummation of the Company’s first Public Offering, $8.1653; or (ii) if such Exercise occurs upon or following the consummation of the Company’s first Public Offering,
the lower of (x) $8.1653 and (y) the initial public offering price per share of Common Stock in such Public Offering, in each case subject to the adjustment set forth in Section 4 (the “Exercise Price”). 

(c) Cashless Exercise. This Warrant may be exercised with respect to any then Exercisable Warrant Shares, in whole or in part, at any
time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B)*(X)] by (A), where: 

 

					
	A	  	=	  	the Market Value on the Business Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise;
			
	B	  	=	  	the Exercise Price of this Warrant, as adjusted hereunder; and
			
	C	  	=	  	the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

  
 2 

 For purposes hereof, “Market Value” means, for any date, the price determined by
the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Public Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the
Public Trading Market on which the Common Stock is then listed or quoted, as reported by Bloomberg L.P. (based on a Business Day from 9:30 a.m., New York time, to 4:02 p.m., New York time); (b) in the event that this Warrant is exercised in
connection with a Public Offering, the per share offering price to the public of the Public Offering, or (c) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Company’s board of directors and reasonably acceptable to the Holder, the fees and expenses of which shall be paid fifty percent (50%) by the Company and fifty percent (50%) by the Holder. 

(d) Mechanics of Exercise. 

(i) Delivery of Certificates Upon Exercise. (a) Subject to the receipt (I) by the Company of a completed Notice of Exercise,
the aggregate Exercise Price in cash in accordance with Section 3(b) (unless the Holder is exercising on a cashless basis in accordance with Section 3(c)), any supporting documents (including, without limitation, a stockholder representation
letter) reasonably requested by the Company from the Holder in the event the transfer agent for the company, if any (the “Transfer Agent”), requires a letter of instruction or legal opinion to complete conversion, in whole or in
part, of the Warrant and movement of any Warrant Shares, and the Warrant and/or any certificate or certificates representing this Warrant, and (II) by the Company or the Transfer Agent of any documents or paperwork required or requested by the
Transfer Agent in connection with the exercise of the Warrant (including, without limitation, an instruction letter or letters prepared, executed and medallion-guaranteed by the Holder’s brokers and/or custodians) and (b) assuming the
Company has not objected to the Notice of Exercise in accordance with Section 3(a), evidence of the Warrant Shares purchased hereunder shall be transmitted by the Company or the Transfer Agent, as applicable, to the Holder by
(x) crediting the account of the Holder’s prime broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”), for which the account number is specified in the Notice of Exercise, if the
Company is then a participant in such system and this Warrant is being exercised via cashless exercise following the required holding period under Rule 144 promulgated under the Securities Act of 1933, as amended (“Rule 144”), (y)
by book-entry in the books and records of the Company, or (z) otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise, in the case of each of clause (x), (y) and (z) of this sentence, by the date
that is three (3) Business Days after the delivery of the last of the items and payment of the aggregate Exercise Price set forth above (including by cashless exercise, if permitted) described in clause (a) of this sentence (such date, the
“Warrant Share Delivery Date”). The then Exercisable Warrant Shares shall be deemed to have been issued, and Holder or any other person designated as the recipient thereof in the Notice of Exercise shall be deemed to have become a
holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any,
pursuant to Section 3(d) (vi) prior to the issuance of such shares, having been paid. 

  
 3 

 (ii) Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in
part, the Company shall, at the time of delivery of the evidence representing the issued Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,
which new Warrant shall in all other respects be identical with this Warrant and, if such Warrants are certificated, a new certificate or certificates representing the new Warrant. 

(iii) [Intentionally omitted.] 

(iv) [Intentionally omitted.] 

(v) No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such
fraction multiplied by the Exercise Price or round up to the next whole share. 
 (vi) Charges, Taxes and Expenses. Issuance of
certificates for Exercisable Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the
Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other
than the name of the Holder (in accordance with and subject to the provisions of Section 5), this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day
processing of any Notice of Exercise. 
 (vii) Closing of Books. The Company will not close its stockholder books or records in any
manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof. 
 Section 4. Certain Adjustments. 

(a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued
by the Company (x) upon exercise of this Warrant or (y) pursuant to a stock option plan or any similar employee compensation plan that is approved by the Company’s board of directors), (ii) subdivides outstanding shares of Common
Stock into a larger number of shares, or (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, , then in each such case the Exercise Price shall be

  
 4 

 
multiplied by a fraction of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares
of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this Section 4(a) shall become effective immediately after the effective date or payment date, as applicable, of such dividend, distribution, subdivision, or combination. 

(b) [Intentionally omitted.] 
 (c)
[Intentionally omitted.] 
 (d) Fundamental Transaction. If a Fundamental Transaction occurs at any time while this Warrant is
outstanding, then (i) all unvested Warrant Shares shall vest and become Exercisable Warrant Shares immediately prior to the consummation of the Fundamental Transaction (except in the case of a Fundamental Transaction that is described in clause
(iii) of the definition thereof and that does not result in a change in control of the Company), and (ii) upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the consummation of such Fundamental Transaction, at the option of the Holder, the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction. For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it
receives upon any exercise of this Warrant following such Fundamental Transaction. 
 For purposes hereof, “Fundamental
Transaction” means the consummation of any transaction, or a series of related transactions, in which the Company, directly or indirectly, (i) consummates a stock sale to, or effects any merger, consolidation or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with, another Person or group of Persons, whereby, in the case of any transaction(s) under
this clause (i), such other Person or group of Persons acquires more than 50% of the total voting power of the then outstanding shares of capital stock of the Company, (ii) effects any sale, lease, license, assignment, transfer, conveyance or
other disposition of all or substantially all of its assets or (iii) effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively
converted into or exchanged for other securities, cash or property, provided that in no event shall a Public Offering be deemed a Fundamental Transaction. 

  
 5 

 (e) Calculations. All calculations under this Section 4 shall be
made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 4, the number of shares of Common Stock or capital stock of the Company, as applicable, deemed to be outstanding
as of a given date shall be the sum of the number of shares of Common Stock or, for purposes of the definition of “Fundamental Transaction”, capital stock of the Company (excluding treasury shares, if any) outstanding. 

(f) Notice to Holder. 

(i) Adjustment to Exercise Price. Whenever there occurs an event that would require adjustment of the Exercise Price pursuant to any
provision of this Section 4, the Company shall promptly mail to the Holder a notice setting forth the then applicable Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares then issuable and setting
forth a brief statement of the facts requiring such adjustment. For purposes hereof, a notice delivered within ten (10) calendar days of an event resulting in an adjustment shall be deemed to have been timely delivered. 

(ii) Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which
the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall
authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered to the Holder at its last address or facsimile number as it shall appear upon
the Warrant Register of the Company, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be
determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivering thereof shall not affect the validity of the corporate action required to be specified in such notice. If the Company is subject to Section 13 or Section 15(d) of the Securities Exchange Act of 1934,
as amended, at the time of any notice provided hereunder, to the extent that such notice constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein. 

  
 6 

 Section 5. Transfer of Warrant. 

(a) Transferability. The Holder shall not, in whole or in part, directly or indirectly, transfer, assign, sell, gift-over, hedge,
pledge, hypothecate or otherwise dispose of this Warrant and all rights hereunder, or, prior to the Company’s first Public Offering, the Warrant Shares (a “Transfer”), unless (i) the Holder shall have received the prior
written consent of the Company (such consent not to be unreasonably withheld) or (ii) the transferee is an Affiliate of Acacia Research Corporation (“Acacia”) (i) which is Controlled by Acacia and (ii) at least a majority
of the equity securities of which Acacia owns, directly or indirectly. The Holder further agrees not to make any disposition of all or any portion of the Warrant Shares unless and until (i) the transferee has agreed in writing for the benefit
of the Company to make such representations and warranties as are reasonable and customary in a private placement of securities and the undertakings set out in Section 6(d) of the Secured Promissory Note, mutatis mutandis, and
(ii) the Holder has (A) notified the Company of the proposed disposition, (B) furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and (C) if requested by the Company,
furnished the Company with an opinion of counsel reasonably satisfactory to the Company that such disposition will not require registration under the Securities Act. The Holder agrees not to make any disposition of any of the Warrant Shares to
(I) any of the Company’s competitors, as determined in good faith by the Company, or (II) without the prior consent of the board of directors of the Company (not to be unreasonably withheld), any Person or group of Persons who has
filed a Schedule 13D or would, as a result of acquiring any Warrant Shares from the Holder, be required to file under Schedule 13D. Any Transfer of this Warrant or any Warrant Shares in violation of the terms and conditions of this Warrant,
including the immediately preceding provisions of this Section 5(a), will be null and void ab initio. Subject to compliance with applicable federal and state security laws, any Transfer permitted under this Section 5(a) shall occur upon
surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds
sufficient to pay any transfer taxes payable upon the making of such transfer. In connection with any such Transfer (if made other than pursuant to an effective registration statement under the Securities Act), the Company may require the transferor
thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such Transfer
does not require registration of such transferred securities under the Securities Act. Upon (i) such surrender, (ii) if required, such payment, and (iii) if required, such opinion, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. 

(b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 5(a), as to any Transfer which may be
involved in such division or combination, the Company shall execute and 

  
 7 

 
deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. 

(c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any
distribution to the Holder, and for all other purposes, absent actual notice to the contrary. 
 Section 6. Representations and
Warranties of the Holder. 
 (a) Purchase for Own Account. This Warrant and the Warrant Shares will be acquired for investment for
the Holder’s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of the Securities Act and the Holder has no present intention, and upon exercise or conversion will have no intention,
of selling or engaging in any public distribution of the same except pursuant to a registration or exemption. The Holder also represents that the Holder has not been formed for the specific purpose of acquiring this Warrant or the Warrant Shares.

 (b) Disclosure of Information. The Holder has received or has had full access to all the information it considers necessary or
appropriate to make an informed investment decision with respect to the acquisition of this Warrant and the Warrant Shares. The Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and
conditions of the offering of this Warrant and the Warrant Shares and to obtain additional information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any
information furnished to the Holder or to which the Holder has access. 
 (c) Investment Experience. The Holder understands that the
purchase of this Warrant and the Warrant Shares involves substantial risk. The Holder acknowledges that the Holder can bear the economic risk of such Holder’s investment in this Warrant and the Warrant Shares and has such knowledge and
experience in financial or business matters that the Holder is capable of evaluating the merits and risks of its investment in this Warrant and the Warrant Shares. 

(d) Accredited Investor Status. The Holder is an “accredited investor” within the meaning of Regulation D promulgated under
the Securities Act. 
 (e) The Securities Act. The Holder understands that this Warrant and the Warrant Shares have not been
registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment intent as expressed herein. The Holder understands that this
Warrant and the Warrant Shares must be held indefinitely unless subsequently registered under the Securities Act and qualified under applicable state securities laws, or unless exemption from such registration and qualification are otherwise
available. The Holder further understands that 

  
 8 

 
settlement of this Warrant is to be made in shares of Common Stock and, for the elimination of doubt, the fact that the shares of Common Stock delivered on exercise of this Warrant will not be
registered under the Securities Act (as defined below) will not in any way require the Company to settle this Warrant otherwise than in shares of Common Stock, including, without limitation, that there is no circumstance that would require the
Company to settle this Warrant in cash. 
 Section 7. Miscellaneous. 

(a) Legends. All certificates evidencing the Warrant Shares shall bear the following legend: 

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS
OF ANY STATE. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE
REASONABLY ACCEPTABLE TO THE COMPANY. 
 (b) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any
voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 3(d)(i). 

(c) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, the posting by the Holder of a bond in customary amount as the
Company may reasonably require as indemnity or security reasonably satisfactory to it, and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of
like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate. 
 (d) Authorized Shares. 

(i) The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its
officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable
action as may be necessary to assure that such Warrant Shares may be issued as provided herein 

  
 9 

 
without violation of any applicable law or regulation, or of any requirements of the Public Trading Market. The Company covenants that all Warrant Shares which may be issued upon the exercise of
the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and
free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue). 

(ii) Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any
of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant
against impairment. Without limiting the generality of the foregoing, the Company will (A) not increase the par value of any Warrant Shares above the amount payable therefor upon exercise immediately prior to such exercise of which the Company
has received a Notice of Exercise, (B) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and
(C) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this
Warrant. 
 (iii) Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is
exercisable or in the Exercise Price, in each case pursuant to Section 4, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof. 
 (e) Jurisdiction. All disputes concerning the construction, validity, enforcement and interpretation of this
Warrant shall be resolved in accordance with Section 14 of the Secured Promissory Note, mutatis mutandis. 
 (f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered pursuant to an effective registration statement and if the Holder does not utilize cashless exercise of this Warrant,
will have restrictions upon resale imposed by state and federal securities laws and may have restrictions on resale in certain instances even if the Holder does utilize cashless exercise. 

(g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of any of the Transaction Agreements, if the Company willfully and knowingly fails to comply with any
provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees,
including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder. 

  
 10 

 (h) Notices. Any notice, request or other document required or permitted to be given or
delivered to the Holder by the Company shall be delivered in accordance with Section 17 of the Secured Promissory Note, mutatis mutandis. 

(i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to
purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is
asserted by the Company or by creditors of the Company. 
 (j) Remedies. The Holder, in addition to being entitled to exercise all
rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach
by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate. 

(k) Successors and Assigns. Subject to applicable securities laws and compliance with Section 5(a), this Warrant and the rights and
obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder. The Company may assign its rights and obligations under this
Warrant without the written consent of the Holder or any holder of Warrant Shares to any purchaser of all or substantially all of the Company’s assets or capital stock or another acquirer of the Company or its business through a Fundamental
Transaction. The provisions of this Warrant are intended to be for the benefit of any permitted Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares. 

(l) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the
Holder. 
 (m) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of
such provisions or the remaining provisions of this Warrant. 
 (n) Headings. The headings used in this Warrant are for the
convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant. 
 [Signature Page Follows] 

  
 11 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto
duly authorized as of the date first above indicated. 
  

			
	 Company:
  

VERITONE, INC.

		
	By: 	 	  

		 	Name:
		 	Title:
		 	
	 Holder:
  

ACACIA RESEARCH CORPORATION

		
	By: 	 	  

		 	Name:
		 	Title:

 [Signature Page to Form of 10% Warrant] 

 NOTICE OF EXERCISE 

TO: VERITONE, INC. 
 (1) The undersigned
hereby elects to purchase Warrant Shares of the Company pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. 

(2) Payment shall take the form of (check applicable box): 

[    ] in lawful money of the United States; or 

[    ] [if permitted] the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set
forth in Section 3(c) of this Warrant, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in Section 3(c). 

(3) Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is
specified below: 
  
  

The Warrant Shares shall be delivered (a) to the following DWAC Account Number, (b) by book-entry in the books and records of the Company, or
(c) by physical delivery of a certificate to the following address: 
  

 
  

 
  

 
 Name of Investing Entity:
ACACIA RESEARCH CORPORATION 
  

	
	Signature of Authorized Signatory of Investing
Entity:                                      
                                         
                                        

	
	Name of Authorized Signatory:
                                        
                                         
                                         
                                 
	
	Title of Authorized Signatory:
                                        
                                         
                                         
                                    
	
	Date:                                   
                                         
                                         
                                         
                                         

 ASSIGNMENT FORM 

(To assign the foregoing warrant, 

execute this form and supply required information. 

Do not use this form to exercise the warrant.) 

VERITONE, INC. 
 FOR VALUE
RECEIVED, [                ] all of or [                ] shares of the foregoing Warrant
and all rights evidenced thereby are hereby assigned to
                                         
                whose address is
                                         
               . 
  

			
	 Dated: __________, ______
	  	 Holder’s Signature:
                                         
               

		
		  	 Holder’s Address:
                                        
                  

		  	
                   
                                         
                            

		  	
                   
                                         
                            

Signature Guaranteed:                    
                                         
                                         
                                         
                           

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any
change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant. 

[The remainder of this page is intentionally left blank.]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]